Attention Members: Manufacturer recall of Ranitidine Tablets & Capsules

Manufacturer Dr. Reddy’s is voluntarily recalling all of its ranitidine medications sold in the United States, including over-the-counter products and prescription products, due to confirmed contamination of N-Nitrosodimethylamine (NDMA) which is above the levels established by the U.S. Food and Drug Administration (FDA). NDMA is considered a substance that could cause cancer based on results from laboratory tests. On November 13, 2019, the FDA stated that this is a Class II Recall for all ranitidine products with an expiration date of September 2019 to March 2022.

To date, Dr. Reddy’s has not received any reports of adverse events related to the recall of Dr. Reddy’s ranitidine products.

Your health and safety is important. Please talk to your doctor about this recall at your next visit.

Visit https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/dr-reddys-confirms-its-voluntary-nationwide-recall-all-ranitidine-products-us-market to learn more about this recall. You can also call Horizon NJ Health Pharmacy Help Desk at 1-800-682-9094 x81016 (TTY 711), Monday through Friday, 8 a.m. to 6:30 p.m. and Saturday 8 a.m. to 4:30 p.m., Eastern Time.

Published on: December 4, 2019, 01:10 AM ET
Last updated on: December 4, 2019, 01:14 AM ET